β-glucan-activated human b lymphocytes participate in innate immune responses by releasing proinflammatory cytokines and stimulating neutrophil chemotaxis

Journal of Immunology

Volumn 195, Issue 11, 2015, Pages 5318-5326

  Ali, Mohamed F ^a   Driscoll, Christopher B ^a   Walters, Paula R ^a   Limper, Andrew H ^a   Carmona, Eva M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; CPG OLIGODEOXYNUCLEOTIDE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; DECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE SYK; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; CONDITIONED MEDIUM; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; LECTIN; OLIGODEOXYRIBONUCLEOTIDE; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE; SYK PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR;

ARTICLE; ASPERGILLUS; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; MYCOSIS; NEUTROPHIL CHEMOTAXIS; PNEUMOCYSTIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; AGONISTS; B LYMPHOCYTE; BIOSYNTHESIS; CELL PROLIFERATION; CONDITIONED MEDIUM; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; NEUTROPHIL; PHARMACOLOGY; SECRETION (PROCESS); T LYMPHOCYTE;

B-LYMPHOCYTES; BETA-GLUCANS; CELL PROLIFERATION; CHEMOTAXIS, LEUKOCYTE; CULTURE MEDIA, CONDITIONED; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN M; INTERLEUKIN-6; INTERLEUKIN-8; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; NEUTROPHILS; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN-TYROSINE KINASES; SYK KINASE; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 9; TRANSCRIPTION FACTOR AP-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84948800029     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500559     Document Type: Article

References (46)

1. Gerondakis, S., R. J. Grumont, and A. Banerjee. 2007. Regulating B-cell activation and survival in response to TLR signals. Immunol. Cell Biol. 85: 471-475.
2. Meyer-Bahlburg, A., and D. J. Rawlings. 2012. Differential impact of Toll-like receptor signaling on distinct B cell subpopulations. Front. Biosci. (Landmark Ed. ) 17: 1499-1516.
3. Fillatreau, S. 2013. Cytokine-producing B cells as regulators of pathogenic and protective immune responses. Ann. Rheum. Dis. 72(Suppl 2): ii80-ii84.
4. Yehudai, D., A. Snir, R. Peri, K. Halasz, T. Haj, M. Odeh, and A. Kessel. 2012. B cell-activating factor enhances interleukin-6 and interleukin-10 production by ODN-activated human B cells. Scand. J. Immunol. 76: 371-377.
5. Klinman, D. M., A. K. Yi, S. L. Beaucage, J. Conover, and A. M. Krieg. 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93: 2879-2883.
6. Hartmann, G., and A. M. Krieg. 2000. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J. Immunol. 164: 944-953.
7. Wagner, M., H. Poeck, B. Jahrsdoerfer, S. Rothenfusser, D. Prell, B. Bohle, E. Tuma, T. Giese, J. W. Ellwart, S. Endres, and G. Hartmann. 2004. IL-12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA. J. Immunol. 172: 954-963.
8. Krieg, A. M., A. K. Yi, S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374: 546-549.
9. Krieg, A. M. 2003. CpG motifs: the active ingredient in bacterial extracts? Nat. Med. 9: 831-835.
10. Karageorgopoulos, D. E., J. M. Qu, I. P. Korbila, Y. G. Zhu, V. A. Vasileiou, and M. E. Falagas. 2013. Accuracy of b-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin. Microbiol. Infect. 19: 39-49.
11. Odabasi, Z., G. Mattiuzzi, E. Estey, H. Kantarjian, F. Saeki, R. J. Ridge, P. A. Ketchum, M. A. Finkelman, J. H. Rex, and L. Ostrosky-Zeichner. 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39: 199-205.
12. Theel, E. S., D. J. Jespersen, S. Iqbal, J. E. Bestrom, L. O. Rollins, L. J. Misner, B. J. Markley, J. Mandrekar, L. M. Baddour, A. H. Limper, et al. 2013. Detection of (1, 3)-b-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia 175: 33-41.
13. Brown, G. D., and S. Gordon. 2001. Immune recognition. A new receptor for beta-glucans. Nature 413: 36-37.
14. Carmona, E. M., T. J. Kottom, D. M. Hebrink, T. Moua, R. D. Singh, R. E. Pagano, and A. H. Limper. 2012. Glycosphingolipids mediate Pneumocystis cell wall beta-glucan activation of the IL-23/IL-17 axis in human dendritic cells. Am. J. Respir. Cell. Mol. Biol. 47: 50-59.
15. Carmona, E. M., R. Vassallo, Z. Vuk-Pavlovic, J. E. Standing, T. J. Kottom, and A. H. Limper. 2006. Pneumocystis cell wall beta-glucans induce dendritic cell costimulatory molecule expression and inflammatory activation through a Fas-Fas ligand mechanism. J. Immunol. 177: 459-467.
16. LeibundGut-Landmann, S., O. Gross, M. J. Robinson, F. Osorio, E. C. Slack, S. V. Tsoni, E. Schweighoffer, V. Tybulewicz, G. D. Brown, J. Ruland, and C. Reis e Sousa. 2007. Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8: 630-638.
17. Qi, H., T. L. Denning, and L. Soong. 2003. Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect. Immun. 71: 3337-3342.
18. Kumar, H., Y. Kumagai, T. Tsuchida, P. A. Koenig, T. Satoh, Z. Guo, M. H. Jang, T. Saitoh, S. Akira, and T. Kawai. 2009. Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J. Immunol. 183: 8061-8067.
19. Vassallo, R., J. E. Standing, and A. H. Limper. 2000. Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J. Immunol. 164: 3755-3763.
20. Manners, D. J., A. J. Masson, and J. C. Patterson. 1974. The heterogeneity of glucan preparations from the walls of various yeasts. J. Gen. Microbiol. 80: 411-417.
21. Agrawal, S., and S. Gupta. 2011. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and hematopoietic growth factors. J. Clin. Immunol. 31: 89-98.
22. Krieg, A. M. 2002. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20: 709-760.
23. Darce, J. R., B. K. Arendt, X. Wu, and D. F. Jelinek. 2007. Regulated expression of BAFF-binding receptors during human B cell differentiation. J. Immunol. 179: 7276-7286.
24. Hardison, S. E., and G. D. Brown. 2012. C-type lectin receptors orchestrate antifungal immunity. Nat. Immunol. 13: 817-822.
25. Ariizumi, K., G. L. Shen, S. Shikano, S. Xu, R. Ritter, T. Kumamoto, D. Edelbaum, A. Morita, P. R. Bergstresser, and A. Takashima. 2000. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 275: 20157-20167.
26. Brown, G. D., P. R. Taylor, D. M. Reid, J. A. Willment, D. L. Williams, L. Martinez-Pomares, S. Y. Wong, and S. Gordon. 2002. Dectin-1 is a major beta-glucan receptor on macrophages. J. Exp. Med. 196: 407-412.
27. Kawata, K., P. Illarionov, G. X. Yang, T. P. Kenny, W. Zhang, M. Tsuda, Y. Ando, P. S. Leung, A. A. Ansari, and M. Eric Gershwin. 2012. Mincle and human B cell function. J. Autoimmun. 39: 315-322.
28. Willment, J. A., A. S. Marshall, D. M. Reid, D. L. Williams, S. Y. Wong, S. Gordon, and G. D. Brown. 2005. The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells. Eur. J. Immunol. 35: 1539-1547.
29. Graham, L. M., S. V. Tsoni, J. A. Willment, D. L. Williams, P. R. Taylor, S. Gordon, K. Dennehy, and G. D. Brown. 2006. Soluble Dectin-1 as a tool to detect beta-glucans. J. Immunol. Methods 314: 164-169.
30. Brown, G. D. 2006. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat. Rev. Immunol. 6: 33-43.
31. McCann, F., E. Carmona, V. Puri, R. E. Pagano, and A. H. Limper. 2005. Macrophage internalization of fungal beta-glucans is not necessary for initiation of related inflammatory responses. Infect. Immun. 73: 6340-6349.
32. Stein, B., and A. S. Baldwin, Jr. 1993. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NFkappa B. Mol. Cell. Biol. 13: 7191-7198.
33. Kunsch, C., R. K. Lang, C. A. Rosen, and M. F. Shannon. 1994. Synergistic transcriptional activation of the IL-8 gene by NF-kappa B p65 (RelA) and NFIL-6. J. Immunol. 153: 153-164.
34. Mestas, J., and C. C. Hughes. 2004. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172: 2731-2738.
35. Snapper, C. M., K. B. Marcu, and P. Zelazowski. 1997. The immunoglobulin class switch: beyond "accessibility. " Immunity 6: 217-223.
36. Marty, F. M., S. Koo, J. Bryar, and L. R. Baden. 2007. (1-. 3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia. Ann. Intern. Med. 147: 70-72.
37. Sax, P. E., L. Komarow, M. A. Finkelman, P. M. Grant, J. Andersen, E. Scully, W. G. Powderly, and A. R. Zolopa, AIDS Clinical Trials Group Study A5164 Team. 2011. Blood (1-. 3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin. Infect. Dis. 53: 197-202.
38. Józefowski, S., Z. Yang, J. Marcinkiewicz, and L. Kobzik. 2012. Scavenger receptors and b-glucan receptors participate in the recognition of yeasts by murine macrophages. Inflamm. Res. 61: 113-126.
39. van Bruggen, R., A. Drewniak, M. Jansen, M. van Houdt, D. Roos, H. Chapel, A. J. Verhoeven, and T. W. Kuijpers. 2009. Complement receptor 3, not Dectin-1, is the major receptor on human neutrophils for beta-glucan-bearing particles. Mol. Immunol. 47: 575-581.
40. Martin-Garrido, I., E. M. Carmona, U. Specks, and A. H. Limper. 2013. Pneumocystis pneumonia in patients treated with rituximab. Chest 144: 258-265.
41. Bonilla-Abadía, F., J. F. Betancurt, J. C. Pineda, J. D. Vélez, G. J. Tobón, and C. A. Cañas. 2014. Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy. Clin. Rheumatol. 33: 415-418.
42. Chang, H., H. C. Yeh, Y. C. Su, and M. H. Lee. 2008. Pneumocystis jiroveci pneumonia in patients with non-Hodgkin's lymphoma receiving chemotherapy containing rituximab. J. Chin. Med. Assoc. 71: 579-582.
43. Lund, F. E., M. Hollifield, K. Schuer, J. L. Lines, T. D. Randall, and B. A. Garvy. 2006. B cells are required for generation of protective effector and memory CD4 cells in response to Pneumocystis lung infection. J. Immunol. 176: 6147-6154.
44. Hoyt, T. R., E. Dobrinen, I. Kochetkova, and N. Meissner. 2015. B cells modulate systemic responses to Pneumocystis murina lung infection and protect ondemand hematopoiesis via T cell-independent innate mechanisms when type I interferon signaling is absent. Infect. Immun. 83: 743-758.
45. Puga, I., M. Cols, C. M. Barra, B. He, L. Cassis, M. Gentile, L. Comerma, A. Chorny, M. Shan, W. Xu, et al. 2012. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat. Immunol. 13: 170-180.
46. Limper, A. H., K. P. Offord, T. F. Smith, and W. J. Martin, II. 1989. Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am. Rev. Respir. Dis. 140: 1204-1209.